Research & development

Buckingham Palace built with Jurassic period microbes

22 January, 2018

Buckingham Palace in London, the Pentagon in Virginia and the Empire State Building in New York City have something in common, reveals a new study.

The silent revolution in molecular biology

18 January, 2018

Animal feed that's easier to digest. Potatoes that don't go brown. And an improved industrial oil.

Study raises concerns over animal trials

16 January, 2018

A recent investigation raises concerns over poor quality, lack of regulation and misrepresentation of animal studies for drug development.

Malaria mystery solved

11 January, 2018

An international collaboration, led by Melbourne researchers, has solved a longstanding malaria mystery.

Nucleic acids and immunity

15 December, 2017 by Mansi Gandhi

Dr Michael Gantier, Research Group Head, Nucleic Acids and Innate Immunity at the Hudson Institute in Melbourne, reflects on the latest developments in the field of infection and immunity and his lab's current focus and future plans.

Novel compound may restore immune response in melanoma patients

11 December, 2017

A novel compound may restore immune response in patients with melanoma, according to a study presented at the ESMO Immuno Oncology Congress 2017 held in Geneva, Switzerland.

Heart attack or chest pain? Take this diagnostic test and find out

04 December, 2017

Upstream Medical Technologies has developed a biomarker-based diagnostic test to rule out the risk of imminent heart attack for the significant number of people presenting at hospital with chest pain.

Australian-developed risk scoring system predicts childhood leukaemia relapse

04 December, 2017

Australian researchers have developed a new risk scoring system for children with leukaemia based on missing DNA fragments or ‘microdeletions’.

Australia and Sri Lanka partner for kidney research

20 November, 2017

Australian and Sri Lankan medical researchers have forged a new action plan to investigate the causes of a particular form of chronic kidney disease.

Polymeric materials with molecular recognition capabilities

20 November, 2017

University of Leicester experts in association with the spin-off company MIP Diagnostics have developed polymeric materials with molecular recognition capabilities which hold the potential to outperform natural antibodies in various diagnostic applications.

Scientists grow genetically modified skin using stem cells

09 November, 2017

Scientists have reconstructed a fully functional epidermis, covering approximately 80% of the total body surface area, for a seven-year-old patient with a genetic skin disease called Junctional Epidermolysis Bullosa (JEB).

One-click analysis of gene expression data derived from 556 tissues, cells

08 November, 2017

A group of international researchers has developed a web tool, RefEx, that can easily search gene expression data available in public databases.

Antibiotic-resistant staph infections occurring more in Australian communities, not hospitals

31 October, 2017 | Supplied by: Australian National University

Research led by ANU has found that the proportion of 'staph' infections resistant to antibiotics has increased in Australia since 2000, with most cases now occurring in the community rather than in hospitals.

3D map of molecular scaffold SgK223 to help develop new cancer treatments

30 October, 2017

Melbourne researchers have produced a three-dimensional (3D) map of a molecular 'scaffold' called SgK223, known to play a critical role in the development and spread of aggressive breast, colon and pancreatic cancers.

MSD and UniQuest to jointly develop immuno-oncology therapies

30 October, 2017

Global healthcare company MSD and the University of Queensland's commercialisation company, UniQuest, have partnered to develop a platform for new immuno-oncology therapies.

  • All content Copyright © 2019 Westwick-Farrow Pty Ltd